[{"headers": [["Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Millions, $ in Millions", "3 Months Ended"], ["Apr. 01, 2017", "Mar. 26, 2016"]], "sections": ["Income Statement [Abstract]", "Net loss per share", "Shares used in per share calculation"], "data": [["Net revenue", "$ 984", "$ 832"], ["Cost of sales", "653", "563"], ["Gross margin", "331", "269"], ["Research and development", "266", "242"], ["Marketing, general and administrative", "121", "105"], ["Restructuring and other special charges, net", "0", "(3)"], ["Licensing gain", "(27)", "(7)"], ["Operating loss", "(29)", "(68)"], ["Interest expense", "(32)", "(40)"], ["Other expense, net", "(5)", "0"], ["Loss before equity loss and income taxes", "(66)", "(108)"], ["Provision for income taxes", "5", "1"], ["Equity loss in investee", "(2)", "0"], ["Net loss", "$ (73)", "$ (109)"], ["Basic (in usd per share)", "$ (0.08)", "$ (0.14)"], ["Diluted (in usd per share)", "$ (0.08)", "$ (0.14)"], ["Basic (in shares)", "939", "793"], ["Diluted (in shares)", "939", "793"]]}, {"headers": [["Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions", "Apr. 01, 2017", "Dec. 31, 2016"]], "sections": ["Current assets:", "Current liabilities:", "Capital stock:"], "data": [["Cash and cash equivalents", "$ 722", "$ 1,264"], ["Marketable securities", "221", "0"], ["Accounts receivable, net", "494", "311"], ["Inventories, net", "839", "751"], ["Prepaid expenses", "73", "63"], ["Prepayment and other receivables - related parties", "31", "32"], ["Other current assets", "118", "109"], ["Total current assets", "2,498", "2,530"], ["Property, plant and equipment, net", "180", "164"], ["Goodwill", "289", "289"], ["Investment: equity method", "58", "59"], ["Other assets", "274", "279"], ["Total assets", "3,299", "3,321"], ["Accounts payable", "529", "440"], ["Payables to related parties", "329", "383"], ["Accrued liabilities", "385", "391"], ["Other current liabilities", "67", "69"], ["Deferred income on shipments to distributors", "62", "63"], ["Total current liabilities", "1,372", "1,346"], ["Long-term debt, net", "1,408", "1,435"], ["Other long-term liabilities", "110", "124"], ["Commitments and Contingencies", "", ""], ["Common stock, par value $0.01; 1,500 shares authorized on April 1, 2017 and December 31, 2016; shares issued: 953 on April 1, 2017 and 949 shares on December 31, 2016; shares outstanding: 942 on April 1, 2017 and 935 shares on December 31, 2016", "9", "9"], ["Additional paid-in capital", "8,379", "8,334"], ["Treasury stock, at cost (11 shares on April 1, 2017 and 14 shares on December 31, 2016)", "(99)", "(119)"], ["Accumulated deficit", "(7,876)", "(7,803)"], ["Accumulated other comprehensive loss", "(4)", "(5)"], ["Total stockholders\u2019 equity", "409", "416"], ["Total liabilities and stockholders\u2019 equity", "$ 3,299", "$ 3,321"]]}, {"headers": [["Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions", "3 Months Ended"], ["Apr. 01, 2017", "Mar. 26, 2016"]], "sections": ["Cash flows from operating activities:", "Adjustments to reconcile net loss to net cash used in operating activities:", "Changes in operating assets and liabilities:", "Cash flows from investing activities:", "Cash flows from financing activities:", "Non-cash investing and financing activities:"], "data": [["Net loss", "$ (73)", "$ (109)"], ["Depreciation and amortization", "34", "33"], ["Stock-based compensation expense", "23", "16"], ["Non-cash interest expense", "9", "4"], ["Loss on debt redemption", "4", "0"], ["Other", "5", "(5)"], ["Accounts receivable", "(183)", "26"], ["Inventories", "(88)", "3"], ["Prepayment and other receivables - related parties", "1", "7"], ["Prepaid expenses and other assets", "(30)", "22"], ["Payables to related parties", "(54)", "(12)"], ["Accounts payable, accrued liabilities and other", "53", "(27)"], ["Net cash used in operating activities", "(299)", "(42)"], ["Purchases of property, plant and equipment", "(23)", "(26)"], ["Purchases of available-for-sale securities", "(221)", "0"], ["Other", "(2)", "0"], ["Net cash used in investing activities", "(246)", "(26)"], ["Proceeds from issuance of common stock under stock-based compensation equity plans", "8", "0"], ["Other", "(5)", "(1)"], ["Net cash provided by (used in) financing activities", "3", "(1)"], ["Net decrease in cash and cash equivalents", "(542)", "(69)"], ["Cash and cash equivalents at beginning of period", "1,264", "785"], ["Cash and cash equivalents at end of period", "722", "716"], ["Purchases of property, plant and equipment, accrued but not paid", "11", "0"], ["Issuance of common stock to partially settle long-term debt", "$ 38", "$ 0"]]}]